Phillips J, Alderson T, Sikora K, Watson J
Department of Neurosurgery, St. Laurence's Hospital, Dublin.
J Neurol Neurosurg Psychiatry. 1983 May;46(5):388-92. doi: 10.1136/jnnp.46.5.388.
Human monoclonal antibodies were produced by fusing intratumoral lymphocytes from patients with malignant gliomas with a human myeloma line. One antibody was selected for further study after screening for binding activity to glioma cell lines. The patient from whom it was derived developed recurrent glioma. 1 mg of antibody was purified, radiolabelled with 131I, and administered intravenously. The distribution of antibody was determined in the blood, CSF and tumour cyst fluid and compared with that of a control human monoclonal immunoglobulin. Antibody localisation in the tumour was observed and confirmed by external scintiscanning.
通过将恶性胶质瘤患者的瘤内淋巴细胞与一种人骨髓瘤细胞系融合来制备人单克隆抗体。在筛选出与胶质瘤细胞系的结合活性后,选择了一种抗体进行进一步研究。产生该抗体的患者发生了复发性胶质瘤。纯化1毫克抗体,用131I进行放射性标记,然后静脉注射。测定抗体在血液、脑脊液和肿瘤囊液中的分布,并与对照人单克隆免疫球蛋白的分布进行比较。通过外部闪烁扫描观察并确认抗体在肿瘤中的定位。